Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Arthritis Rheum. 2010 Sep;62(9):2582–2591. doi: 10.1002/art.27580

Table 2.

Revised categories and weights after inclusion of additional joint involvement category*

Criterion and category Score
Joint involvement (pattern and distribution)
  1 medium-large joint 0.0
  Asymmetric medium-large joints (at least 2 joints) 10.1
  Symmetric medium-large joints (at least 2 joints) 16.0
  1–3 small joints (hands/feet or wrists) 21.0
  ≥4 asymmetric small joints (hands/feet or wrists) 27.7
  4–10 symmetric small joints (hands/feet or wrists) 29.4
  >10 joints including hands/feet or wrists 50.5
Serology (ACPA or RF)
  RF negative and ACPA negative 0.0
  Low-positive (RF positive and/or ACPA positive) 21.8
  High-positive (RF positive and/or ACPA positive) 33.6
Acute-phase reactants (CRP or ESR)
  Normal 0.0
  Abnormal 5.9
Duration of synovitis
  <4 weeks 0.0
  4–8 weeks 8.4
  >8 weeks 10.1
*

Scores from each criterion are summed to derive the total score, which represents the probability of developing rheumatoid arthritis (RA).

ACPA = anti–cyclic citrullinated protein; RF = rheumatoid factor; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate.